Mylan N.V. (MYL) Stock Rating Upgraded by Citigroup Inc.
Mylan N.V. (NASDAQ:MYL) was upgraded by research analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating in a report issued on Wednesday, The Fly reports.
Several other research firms have also issued reports on MYL. Deutsche Bank AG lowered their price target on shares of Mylan N.V. from $52.00 to $51.00 and set a “buy” rating on the stock in a research report on Tuesday, April 18th. BMO Capital Markets started coverage on shares of Mylan N.V. in a research note on Monday, May 1st. They set an “outperform” rating and a $50.00 price objective for the company. Royal Bank Of Canada reduced their price objective on shares of Mylan N.V. from $39.00 to $36.00 and set a “sector perform” rating for the company in a research note on Thursday, May 11th. Zacks Investment Research cut shares of Mylan N.V. from a “hold” rating to a “sell” rating in a research note on Monday, May 15th. Finally, Cowen and Company reissued a “market perform” rating and issued a $43.00 price target (down previously from $55.00) on shares of Mylan N.V. in a research note on Sunday, May 21st. Two research analysts have rated the stock with a sell rating, ten have given a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $47.83.
Shares of Mylan N.V. (NASDAQ:MYL) opened at 30.13 on Wednesday. The firm’s 50-day moving average is $36.82 and its 200 day moving average is $38.96. The company has a market capitalization of $16.16 billion, a PE ratio of 24.36 and a beta of 1.27. Mylan N.V. has a 12 month low of $29.39 and a 12 month high of $49.42.
Mylan N.V. (NASDAQ:MYL) last released its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.18 by $0.08. Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same quarter last year, the firm posted $1.16 earnings per share. The firm’s revenue for the quarter was up 15.7% compared to the same quarter last year. Equities research analysts predict that Mylan N.V. will post $4.51 EPS for the current year.
TRADEMARK VIOLATION WARNING: “Mylan N.V. (MYL) Stock Rating Upgraded by Citigroup Inc.” was posted by American Banking News and is owned by of American Banking News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/08/16/mylan-n-v-myl-stock-rating-upgraded-by-citigroup-inc.html.
In other news, President Rajiv Malik sold 25,000 shares of the business’s stock in a transaction on Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $1,000,000.00. Following the completion of the sale, the president now directly owns 799,855 shares of the company’s stock, valued at $31,994,200. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Anthony Mauro sold 10,000 shares of the business’s stock in a transaction on Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $400,000.00. Following the sale, the insider now directly owns 140,653 shares of the company’s stock, valued at $5,626,120. The disclosure for this sale can be found here. 0.69% of the stock is owned by insiders.
Several hedge funds have recently modified their holdings of MYL. Harvest Management bought a new stake in shares of Mylan N.V. during the third quarter worth about $3,462,000. Meag Munich Ergo Kapitalanlagegesellschaft purchased a new position in shares of Mylan N.V. during the third quarter worth approximately $3,268,000. Eagle Asset Management increased its position in shares of Mylan N.V. by 85.5% in the third quarter. Eagle Asset Management now owns 752,812 shares of the company’s stock worth $30,308,000 after buying an additional 347,018 shares in the last quarter. Water Island Capital increased its position in shares of Mylan N.V. by 817.9% in the third quarter. Water Island Capital now owns 370,088 shares of the company’s stock worth $14,900,000 after buying an additional 329,770 shares in the last quarter. Finally, Janus Capital Management increased its position in shares of Mylan N.V. by 1,608.1% in the third quarter. Janus Capital Management now owns 687,099 shares of the company’s stock worth $27,663,000 after buying an additional 646,874 shares in the last quarter. 71.57% of the stock is owned by hedge funds and other institutional investors.
About Mylan N.V.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.